Javier I. Muñoz‐González

MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis

Mohamad Jawhar, Juliana Schwaab, Iván Álvarez‐Twöse et al. · Journal of Clinical Oncology · 2019 · 123 citations · Full text

Life Sciences, Genetics, Immunology +14

Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications

María Jara‐Acevedo, Cristina Teodósio, Laura Sánchez‐Muñoz et al. · Modern Pathology · 2015 · 111 citations · Full text

Medicine, Hematology, Pathology +11

Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 <i>KIT</i> mutations and review of the literature

Iván Álvarez‐Twöse, Almudena Matito, José Mário Morgado et al. · Oncotarget · 2016 · 99 citations · Full text

Life Sciences, Hematology, Internal Medicine +13

Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression

Andrea Mayado, Cristina Teodósio, Andrés C. García‐Montero et al. · Leukemia · 2015 · 68 citations

Life Sciences, Immunology, Pathology +12

Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis

Javier I. Muñoz‐González, Iván Álvarez‐Twöse, María Jara‐Acevedo et al. · Blood · 2019 · 67 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16